This site is intended for healthcare professionals only

Clinical snapshots. Results from the PCDS survey series: Insulin safety in general practice

One of the aims of the PCDS in 2016 is to encourage discussion within the society and foster the voice of members. As a result, a series of clinical snapshot surveys has been launched. Results of a questionnaire on insulin safety in general practice among PCDS members have been analysed and are presented below.

During May 2016, 174 healthcare professionals completed the survey. Demographics of respondents reflected the multidisciplinary readership of the Journal and those involved in insulin management, with 34.5% practice nurses, 18% diabetes specialist nurses, 6.5% nurse practitioners and consultant nurses, 15% GPs, nearly 10% describing themselves as diabetes leads, and the remainder district, community and hospital nurses, dietitians, podiatrists, pharmacists and consultants.

In total, 89% of those responding personally manage people on insulin within their practice, with 56% initiating insulin as part of an enhanced service. More than three quarters discuss injection technique at every insulin review and 78% inspect injection sites at least annually. However, only just over half had read best practice injection technique guidelines, suggesting this may remain an area of significant educational need (see Figure 1).

A total of 87% are somewhat or very confident adjusting insulin doses, with more than half providing written instructions to support self-titration. Several healthcare professionals provide telephone support, recommending individualised dose adjustments based on reported glucose levels.

The survey explored how knowledgeable and confident the respondents are with newer insulins. One third admitted to not being at all confident using newer insulin concentrations with half very or somewhat confident. In total, 30% were not aware of biosimilar insulins.

Just under a third of respondents stated they are not involved in choice of insulin, but not surprisingly more than 50% felt that cost always or somewhat influences insulin choice. Despite PCDS previously highlighting this as a safety concern (PCDS, 2015), 32% are aware of insulin being drawn out of insulin pen cartridges or prefilled pens, posing a significant risk to patients and professionals.

Approximately two-thirds responded that they had completed an update or training in insulin management but in more than 20% of this group, this took place more than 4 years ago.

Related content
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.